Artiva Biotherapeutics, Inc. ARTV Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Artiva Biotherapeutics, Inc. (ARTV) reported operating lease right-of-use assets in other assets of $9.88M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Artiva Biotherapeutics, Inc.'s operating lease right-of-use assets in other assets decreased by 26.7% year-over-year, from $13.48M to $9.88M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s operating lease right-of-use assets in other assets has grown at a -20.2% compound annual growth rate (CAGR), from $16.55M to $10.53M.